{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:21:04Z","timestamp":1794543664804,"version":"4.9.1"},"reference-count":32,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1136\/thoraxjnl-2014-205587","type":"journal-article","created":{"date-parts":[[2014,9,22]],"date-time":"2014-09-22T21:33:48Z","timestamp":1411421628000},"page":"1073-1079","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":147,"title":["Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial"],"prefix":"10.1136","volume":"69","author":[{"given":"Diana","family":"Bilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Tino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan F","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"De Soyza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven J A","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"O'Dochartaigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H J","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Otero","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard G","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,9,21]]},"reference":[{"key":"key-10.1136\/thoraxjnl-2014-205587-1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/pgmj.2009.091041","article-title":"Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century","volume":"86","author":"Goeminne","year":"2010","journal-title":"Postgrad Med J"},{"key":"key-10.1136\/thoraxjnl-2014-205587-2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.rmed.2007.11.007","article-title":"Bronchiectasis in Central Australia: a young face to an old disease","volume":"102","author":"Steinfort","year":"2008","journal-title":"Respir Med"},{"key":"key-10.1136\/thoraxjnl-2014-205587-3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/adc.2004.066472","article-title":"New Zealand national incidence of bronchiectasis \u201ctoo high\u201d for a developed country","volume":"90","author":"Twiss","year":"2005","journal-title":"Arch Dis Child"},{"key":"key-10.1136\/thoraxjnl-2014-205587-4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ppul.10289","article-title":"Non-CF bronchiectasis: clinical and HRCT evaluation","volume":"35","author":"Chang","year":"2003","journal-title":"Pediatr Pulmonol"},{"key":"key-10.1136\/thoraxjnl-2014-205587-5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","article-title":"Prevalence and economic burden of bronchiectasis","volume":"12","author":"Weycker","year":"2005","journal-title":"Clin Pulmon Med"},{"key":"key-10.1136\/thoraxjnl-2014-205587-6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5694\/j.1326-5377.2010.tb03949.x","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand","volume":"193","author":"Chang","year":"2010","journal-title":"Med J Aust"},{"issue":"(Suppl 1)","key":"key-10.1136\/thoraxjnl-2014-205587-7","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2014-205587-8","first-page":"1071","article-title":"Pharmacological airway clearance strategies in bronchiectasis","volume":"52","author":"Bye","year":"2011","journal-title":"Europena Respir Soc Monogr"},{"key":"key-10.1136\/thoraxjnl-2014-205587-9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1440-1843.2005.00659.x","article-title":"Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum","volume":"10","author":"Daviskas","year":"2005","journal-title":"Respirology"},{"key":"key-10.1136\/thoraxjnl-2014-205587-10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1183\/09031936.00187510","article-title":"Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study","volume":"38","author":"Bilton","year":"2011","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2014-205587-11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1164\/rccm.201109-1666OC","article-title":"Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study","volume":"185","author":"Aitken","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"(Suppl 48)","key":"key-10.1136\/thoraxjnl-2014-205587-12","first-page":"707","article-title":"A placebo controlled trial with inhaled mannitol improves health related quality of life in patients with bronchiectasis","volume":"24","author":"Daviskas","year":"2004","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2014-205587-13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rmed.2011.12.021","article-title":"The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis","volume":"106","author":"Nicolson","year":"2012","journal-title":"Respir Med"},{"key":"key-10.1136\/thoraxjnl-2014-205587-14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"Kellett","year":"2011","journal-title":"Respir Med"},{"key":"key-10.1136\/thoraxjnl-2014-205587-15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.1136\/thoraxjnl-2014-205587-16","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1164\/ajrccm.159.6.9809074","article-title":"Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis","volume":"159","author":"Daviskas","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2014-205587-17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.rmed.2009.10.021","article-title":"Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis","volume":"104","author":"Daviskas","year":"2010","journal-title":"Respir Med"},{"key":"key-10.1136\/thoraxjnl-2014-205587-18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1034\/j.1399-3003.1999.14c30.x","article-title":"The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study","volume":"14","author":"Robinson","year":"1999","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2014-205587-19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1378\/chest.119.2.414","article-title":"The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis","volume":"119","author":"Daviskas","year":"2001","journal-title":"Chest"},{"key":"key-10.1136\/thoraxjnl-2014-205587-20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1440-1843.2007.01107.x","article-title":"Inhaled mannitol changes the sputum properties in asthmatics with mucus hypersecretion","volume":"12","author":"Daviskas","year":"2007","journal-title":"Respirology"},{"key":"key-10.1136\/thoraxjnl-2014-205587-21","first-page":"470","article-title":"Inhaled mannitol improves lung function assessed by forced oscillation in a placebo controlled trial in patients with bronchiectasis","volume":"24","author":"Goldman","year":"2004","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2014-205587-22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1378\/chest.12-1763","article-title":"Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis","volume":"144","author":"Bilton","year":"2013","journal-title":"Chest"},{"key":"key-10.1136\/thoraxjnl-2014-205587-23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcf.2010.08.020","article-title":"Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial","volume":"10","author":"Teper","year":"2011","journal-title":"J Cyst Fibros"},{"key":"key-10.1136\/thoraxjnl-2014-205587-24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann Intern Med"},{"key":"key-10.1136\/thoraxjnl-2014-205587-25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thorax.57.1.15","article-title":"Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors","volume":"57","author":"Angrill","year":"2002","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2014-205587-26","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/thoraxjnl-2012-201983","article-title":"British Thoracic Society national bronchiectasis audit 2010 and 2011","volume":"67","author":"Hill","year":"2012","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2014-205587-27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group","volume":"113","author":"O'Donnell","year":"1998","journal-title":"Chest"},{"issue":"(2 Pt 1)","key":"key-10.1136\/thoraxjnl-2014-205587-28","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.156.2.9607083","article-title":"Validation of the St. George's Respiratory Questionnaire in bronchiectasis","volume":"156","author":"Wilson","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2014-205587-29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1183\/09031936.00159111","article-title":"Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis","volume":"40","author":"Waters","year":"2012","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2014-205587-30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","article-title":"Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation","volume":"182","author":"Sanders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2014-205587-31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1183\/09031936.00119707","article-title":"Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis","volume":"31","author":"Daviskas","year":"2008","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2014-205587-32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcf.2012.11.002","article-title":"Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis","volume":"12","author":"Bilton","year":"2013","journal-title":"J Cyst Fibros"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2014-205587","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T01:46:23Z","timestamp":1601084783000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2014-205587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,21]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,11,11]]},"published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1136\/thoraxjnl-2014-205587"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2014-205587","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718885908.793530597","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718885908.793557657","asserted-by":"object"}]},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,21]]}}}